Aumolertinib is effective in NSCLC
Crossref DOI link: https://doi.org/10.1038/s41571-021-00586-x
Published Online: 2021-11-29
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Romero, Diana
Text and Data Mining valid from 2021-11-29
Version of Record valid from 2021-11-29
Article History
First Online: 29 November 2021